Patent · US Active

ω-Transaminase mutant obtained by DNA synthetic shuffling combined mutation and use

US12152255B2 · kind B2 · utility

0Cited by
0References
4Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 6, 2021
Grant dateNov 26, 2024
Priority date
Expiry dateDec 6, 2041

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/584
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention discloses a ω-transaminase mutant obtained through DNA synthetic shuffling combined mutation. The ω-transaminase mutant is obtained through point mutation of a wild type ω-transaminase from Aspergillus terrus. The amino acid sequence of the wild type ω-transaminase is shown in SEQ ID NO: 1. The mutation site of the ω-transaminase mutant is any one of: (1) F115L-H210N-M150C-M280C; (2) F115L-H210N; (3) F115L-H210N-E253A-I295V; (4) I77L-F115L-E133A-H210N-N245D; (5) I77L-Q97E-F115L-L118T-E253A-G292D; (6) I77L-E133A-N245D-G292D; and (7) H210N-N245D-E253A-G292D. According to the present invention, forward mutations obtained in the previous stage are randomly combined through a DNA synthetic shuffling combined mutation method. It is verified through experiments that this method can effectively improve the probability of forward mutation and increase experimental efficiency and feasibility, and is capable of obtaining mutant enzymes with thermodynamic stability remarkably superior to that of wild enzymes via screening.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.